bexarotene has been researched along with octa-2,4,6-trienoic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grandis, JR; Johnson, DE; Lamph, WW; Lango, M; Miller, L; Song, JI; Wentzel, AL; Xi, S | 1 |
1 other study(ies) available for bexarotene and octa-2,4,6-trienoic acid
Article | Year |
---|---|
Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bexarotene; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; ErbB Receptors; Fatty Acids, Unsaturated; Head and Neck Neoplasms; Humans; Receptors, Retinoic Acid; Retinoids; Signal Transduction; Tetrahydronaphthalenes; Transplantation, Heterologous | 2003 |